PharmaFrontiers Changes Name to Opexa Therapeutics; New Ticker ...

PharmaLive.com (press release) - Newtown,PA,USA
... Opexa was the original developer of Tovaxin(TM), which is being studied for the treatment of multiple sclerosis, and as such represents our past. ...